Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-23
DOI
10.1038/srep21678
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors
- (2014) R. Lyngaa et al. CLINICAL CANCER RESEARCH
- γδ T Cells and Their Potential for Immunotherapy
- (2014) Yan-Ling Wu et al. International Journal of Biological Sciences
- Characterization of functional domains in the Merkel cell polyoma virus Large T antigen
- (2014) Roland Houben et al. INTERNATIONAL JOURNAL OF CANCER
- Cells of Origin in Skin Cancer
- (2014) Jürgen C. Becker et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Universes Collide: Combining Immunotherapy with Targeted Therapy for Cancer
- (2014) J. A. Wargo et al. Cancer Discovery
- Regulation of Ligands for the NKG2D Activating Receptor
- (2013) David H. Raulet et al. Annual Review of Immunology
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Merkel Polyomavirus-Specific T Cells Fluctuate with Merkel Cell Carcinoma Burden and Express Therapeutically Targetable PD-1 and Tim-3 Exhaustion Markers
- (2013) O. K. Afanasiev et al. CLINICAL CANCER RESEARCH
- Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials
- (2013) Tianzhu Qiu et al. Future Oncology
- Tumor-Specific T Cells in Human Merkel Cell Carcinomas: A Possible Role for Tregs and T-Cell Exhaustion in Reducing T-Cell Responses
- (2013) Mitra Dowlatshahi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A cornucopia of human polyomaviruses
- (2013) James A. DeCaprio et al. NATURE REVIEWS MICROBIOLOGY
- Vorinostat Induces Apoptosis and Differentiation in Myeloid Malignancies: Genetic and Molecular Mechanisms
- (2013) Gabriela Silva et al. PLoS One
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
- (2013) E. J. Lipson et al. Cancer Immunology Research
- Type I and II IFNs Inhibit Merkel Cell Carcinoma via Modulation of the Merkel Cell Polyomavirus T Antigens
- (2012) C. Willmes et al. CANCER RESEARCH
- Suppressing T cell motility induced by anti–CTLA-4 monotherapy improves antitumor effects
- (2012) Maria Grazia Ruocco et al. JOURNAL OF CLINICAL INVESTIGATION
- Interferon-γ Up-Regulates Major-Histocompatibility-Complex Class I-Related Chain A Expression and Enhances Major-Histocompatibility-Complex Class I-Related Chain A-Mediated Cytolysis of Human Corneal Epithelium by Natural Killer Cells In Vitro
- (2012) Jiaxu Hong et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Distinct Gene Expression Profiles of Viral- and Nonviral-Associated Merkel Cell Carcinoma Revealed by Transcriptome Analysis
- (2012) Paul W. Harms et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MCV and Merkel cell carcinoma: a molecular success story
- (2012) Reety Arora et al. Current Opinion in Virology
- Human NKG2D-ligands: cell biology strategies to ensure immune recognition
- (2012) Lola Fernández-Messina et al. Frontiers in Immunology
- Immune activation by combination human lymphokine-activated killer and dendritic cell therapy
- (2011) E J West et al. BRITISH JOURNAL OF CANCER
- An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells
- (2011) Roland Houben et al. INTERNATIONAL JOURNAL OF CANCER
- Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator
- (2011) Masahiro Shuda et al. JOURNAL OF CLINICAL INVESTIGATION
- Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival
- (2011) Kelly G. Paulson et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunobiology of Merkel Cell Carcinoma: Implications for Immunotherapy of a Polyomavirus-Associated Cancer
- (2011) Shailender Bhatia et al. Current Oncology Reports
- The role of Sp1 and Sp3 in normal and cancer cell biology
- (2010) Lin Li et al. ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER
- Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system
- (2010) Bianca D. Lemos et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens
- (2010) R. Houben et al. JOURNAL OF VIROLOGY
- NK Cells and γδ T Cells Mediate Resistance to Polyomavirus–Induced Tumors
- (2010) Rabinarayan Mishra et al. PLoS Pathogens
- Spheroid-based drug screen: considerations and practical approach
- (2009) Juergen Friedrich et al. Nature Protocols
- HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer
- (2009) A López-Soto et al. ONCOGENE
- Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features
- (2008) Michelle Heath et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D
- (2008) Noam Stern-Ginossar et al. NATURE IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now